Insulin Release: Synchronizing beta cells in the pancreas
The amount of glucose in the blood is controlled by the hormone insulin, which is released by the pancreas when glucose levels get too high. The hormone is released from beta cells that are organized into spheroid structures within the pancreas known as islets of Langerhans. Like muscle cells in the heart, beta cells are electrically coupled together by gap junctions, and this coupling enables the cells within the islet to coordinate or synchronize their behavior and release insulin in a pulsatile manner.
Gap junctions are thought to be critical for controlling the dynamics of the islets and, hence, insulin secretion. Indeed, mice lacking gap junctions are unable to release insulin in pulses (Head et al., 2012). Gap junction (or electrical) coupling between beta cells has also been shown to weaken with age as insulin secretion declines and individuals become more susceptible to type 2 diabetes (Westacott et al., 2017a).
Recent studies have shown that beta cells can be separated into subpopulations based on their genetic makeup, the proteins they make, and how they behave (Benninger and Hodson, 2018). Some of these subgroups have a greater influence over islet dynamics than others (Stožer et al., 2013; Johnston et al., 2016; Salem et al., 2019; Westacott et al., 2017b; Nasteska et al., 2021). When these cells are disrupted – either by optogenetics or gene overexpression – islet function and insulin secretion decline, reminiscent of what occurs during aging and type 2 diabetes.
These subpopulations of beta cells are not physically connected and instead rely on their intrinsic properties to influence islet dynamics (Johnston et al., 2016; Westacott et al., 2017b; Nasteska et al., 2021). However, the cells in these subpopulations are too few in number to influence electrical coupling by gap junctions (Peercy and Sherman, 2022). Additionally, gap junctions alone cannot explain the activity patterns of the subpopulations identified, or their influence over islet function. So how do these two mechanisms work together to control blood glucose levels? Now, in eLife, Richard Benninger and co-workers – including Jennifer Briggs as first author – report new findings that shine some light on the relationship between beta cell subpopulations and gap junctions (Briggs et al., 2023).
The researchers (who are based at the University of Colorado Anschutz Medical Campus and the University of Birmingham) found that the enzyme glucokinase – which senses changes in blood glucose levels – displayed elevated levels of activity in a subpopulation of beta cells. This resulted in heightened metabolism due to glucokinase breaking down more molecules of glucose to generate the high levels of ATP (usable energy) versus ADP (used energy) required for insulin release, reflecting previous findings (Johnston et al., 2016; Westacott et al., 2017b).
Notably, beta cells were more likely to synchronize their response to glucose if their metabolic activity was similar; moreover, changing these intrinsic properties led to a loss of the beta cell subpopulation. Reducing gap junction coupling also did not stop the beta cells within the islet from synchronizing their activity. It did, however, make them much weaker at transmitting electrical signals across the islet.
It has long been thought that gap junctions are the major driver of synchronized beta cell activity, and that their disruption during diabetes leads to impaired insulin secretion. However, the findings of Briggs et al. suggest that gap junctions are just one piece of the jigsaw, and that cells with similar intrinsic properties – such as metabolic actvity – also drive islet dynamics (Figure 1).

The role of gap junctions and beta cell subpopulations in insulin release.
Within the pancreas, insulin-secreting beta cells are arranged into islets, and are physically coupled together by gap junctions (dark gray rectangles/lines). In the current model (left), gap junctions (pink) spread electrical currents (mV) between beta cells within the islet, resulting in the population displaying similar oscillations of electrical activity (right hand graph, matching waves highlighted in blue) and synchronizing their insulin release. Within the islet are also subpopulations of beta cells with specific intrinsic properties (shaded in dark grey; lower panel), such as higher levels of metabolic activity or producing more usable energy (ATP) than used energy (ADP). These beta cell subpopulations also contribute to coordinated beta cell activity, but how exactly was largely unknown. In the updated model proposed by Briggs et al. (right), the beta subpopulations and gap junctions work together to control islet dynamics. The increased metabolism of the beta subpopulations makes it easier for gap junctions to spread electrical currents across the islet. Disrupting either of these mechanisms (represented by an X symbol) makes it harder for beta cells within the islet to fully synchronize their electrical activity (left hand graph), leading to a decline in insulin secretion. mV = membrane potential.
Image credit: Figure created with BioRender.com.
So which mechanism fails first during diabetes: gap junctions or intrinsic cellular properties? Small decreases in the number of gap junctions and their associated electrical signalling, which occurs during diabetes, would make it much harder for beta cells within a subpopulation to synchronize. On the other hand, small changes in intrinsic cellular properties might render gap junction synchronization much less effective. Complicating matters further, loss of gap junction coupling likely influences the intrinsic properties of beta cells and vice versa. Therefore, the disrupted islet dynamics and impaired insulin release observed in patients with diabetes is probably due in part to both mechanisms failing simultaneously.
The study by Briggs et al. shows that no single mechanism drives synchronized beta cell activity: rather, subpopulations and gap junctions come together to shape islet behaviour. Further computational modelling could help tease out – or even predict – how the critical relationship between beta cell subpopulations and gap junctions influences insulin release. Further experimental work is also warranted to understand how the interplay between beta cell subpopulations and gap junctions is altered during diabetes.
References
-
Beta cell hubs dictate pancreatic islet responses to glucoseCell Metabolism 24:389–401.https://doi.org/10.1016/j.cmet.2016.06.020
-
Do oscillations in pancreatic islets require pacemaker cells?Journal of Biosciences 47:14.https://doi.org/10.1007/s12038-021-00251-6
-
Functional connectivity in islets of Langerhans from mouse pancreas tissue slicesPLOS Computational Biology 9:e1002923.https://doi.org/10.1371/journal.pcbi.1002923
Article and author information
Author details
Publication history
Copyright
© 2024, Peercy and Hodson
This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,515
- views
-
- 156
- downloads
-
- 3
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
In eukaryotes, protein kinase signaling is regulated by a diverse array of post-translational modifications, including phosphorylation of Ser/Thr residues and oxidation of cysteine (Cys) residues. While regulation by activation segment phosphorylation of Ser/Thr residues is well understood, relatively little is known about how oxidation of cysteine residues modulate catalysis. In this study, we investigate redox regulation of the AMPK-related brain-selective kinases (BRSK) 1 and 2, and detail how broad catalytic activity is directly regulated through reversible oxidation and reduction of evolutionarily conserved Cys residues within the catalytic domain. We show that redox-dependent control of BRSKs is a dynamic and multilayered process involving oxidative modifications of several Cys residues, including the formation of intramolecular disulfide bonds involving a pair of Cys residues near the catalytic HRD motif and a highly conserved T-loop Cys with a BRSK-specific Cys within an unusual CPE motif at the end of the activation segment. Consistently, mutation of the CPE-Cys increases catalytic activity in vitro and drives phosphorylation of the BRSK substrate Tau in cells. Molecular modeling and molecular dynamics simulations indicate that oxidation of the CPE-Cys destabilizes a conserved salt bridge network critical for allosteric activation. The occurrence of spatially proximal Cys amino acids in diverse Ser/Thr protein kinase families suggests that disulfide-mediated control of catalytic activity may be a prevalent mechanism for regulation within the broader AMPK family.
-
- Computational and Systems Biology
- Genetics and Genomics
Obesity is a major risk factor for type 2 diabetes, dyslipidemia, cardiovascular disease, and hypertension. Intriguingly, there is a subset of metabolically healthy obese (MHO) individuals who are seemingly able to maintain a healthy metabolic profile free of metabolic syndrome. The molecular underpinnings of MHO, however, are not well understood. Here, we report that CTRP10/C1QL2-deficient mice represent a unique female model of MHO. CTRP10 modulates weight gain in a striking and sexually dimorphic manner. Female, but not male, mice lacking CTRP10 develop obesity with age on a low-fat diet while maintaining an otherwise healthy metabolic profile. When fed an obesogenic diet, female Ctrp10 knockout (KO) mice show rapid weight gain. Despite pronounced obesity, Ctrp10 KO female mice do not develop steatosis, dyslipidemia, glucose intolerance, insulin resistance, oxidative stress, or low-grade inflammation. Obesity is largely uncoupled from metabolic dysregulation in female KO mice. Multi-tissue transcriptomic analyses highlighted gene expression changes and pathways associated with insulin-sensitive obesity. Transcriptional correlation of the differentially expressed gene (DEG) orthologs in humans also shows sex differences in gene connectivity within and across metabolic tissues, underscoring the conserved sex-dependent function of CTRP10. Collectively, our findings suggest that CTRP10 negatively regulates body weight in females, and that loss of CTRP10 results in benign obesity with largely preserved insulin sensitivity and metabolic health. This female MHO mouse model is valuable for understanding sex-biased mechanisms that uncouple obesity from metabolic dysfunction.